Pulmonary hypertension as a dominant clinical picture in a case of amyloidosis and smoldering multiple myeloma

International Journal of Cardiology

Volumn 115, Issue 1, 2007, Pages

  Lehtonen, Jukka ^a   Kettunen, Pasi ^b  

^a Meilahti Hospital   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

Amyloidosis; Multiple myeloma; Pulmonary hypertension

Indexed keywords

AMYLOID; MELPHALAN; PREDNISONE; SILDENAFIL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DYSPNEA; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HEMODYNAMICS; HUMAN; LABORATORY DIAGNOSIS; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

AMYLOIDOSIS; COMORBIDITY; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 33845194640     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.059     Document Type: Article

References (4)

1. Dingli D., Utz J.P., and Gertz M.A. Pulmonary hypertension in patients with amyloidosis. Chest 120 (2001) 1735-1739
2. Shiue S.T., and McNally D.P. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis. Arch Intern Med 148 (1988) 687-689 ja
3. Liao R., Jain M., Teller P., et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 104 (2001) 1594-1597
4. Berghoff M., Kathpal M., Khan F., et al. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol 53 (2003) 725-730